Online citations, reference lists, and bibliographies.
← Back to Search

Overcoming The Challenges In Administering Biopharmaceuticals: Formulation And Delivery Strategies

S. Mitragotri, P. A. Burke, R. Langer
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies and recombinant proteins, poses substantial challenges owing to their large size and susceptibility to degradation. In this Review we highlight recent advances in formulation and delivery strategies — such as the use of microsphere-based controlled-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, and genetic manipulation of biopharmaceutical drugs — and discuss their advantages and limitations. We also highlight current and emerging delivery routes that provide an alternative to injection, including transdermal, oral and pulmonary delivery routes. In addition, the potential of targeted and intracellular protein delivery is discussed.
This paper references
10.1007/s11095-011-0510-x
Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier
K. Chaudhari (2011)
10.1016/S0928-0987(02)00162-8
Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs.
A. A. Raoof (2002)
10.1016/j.jconrel.2013.05.002
A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
V. Gupta (2013)
10.1073/pnas.0700182104
Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets
A. Arora (2007)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1016/j.neuron.2013.10.061
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
J. Niewoehner (2014)
10.1021/bc3006122
Impact of site-specific PEGylation on the conformational stability and folding rate of the Pin WW domain depends strongly on PEG oligomer length.
Brijesh Kumar Pandey (2013)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1517/17425247.4.4.441
Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs
Y-P Chan (2007)
10.1126/scitranslmed.3003651
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach (2012)
10.1126/scitranslmed.3003594
A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
Elizabeth A. Nance (2012)
10.1016/S0168-3659(02)00363-2
Nasal drug delivery--possibilities, problems and solutions.
L. Illum (2003)
10.1007/978-1-4614-0554-2_9
In Situ Forming Systems (Depots)
J. Wright (2012)
10.1200/JCO.2006.24.18_SUPPL.2558
Pharmacokinetics (PK) and immunologic responses in a phase I/II study of a sustained release formulation of IL-2 in renal cell carcinoma (RCC) patients.
S. Oudard (2006)
single and multiple administration studies in type 1 and 2 diabetic rats
Morishita (2006)
Mechanisms and Applications
Tian Yow Tsang (1989)
10.1177/193229680900300312
Clinical Update on Optimal Prandial Insulin Dosing Using a Refined Run-to-Run Control Algorithm
H. Zisser (2009)
A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo
J. Atwal (2013)
10.1016/j.nano.2011.09.007
Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer.
Shikha Gaur (2012)
10.1002/bit.24795
Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor
R. Boado (2013)
a tribute to contributions of Prof
Mitragotri (2013)
10.1038/mt.2009.36
Development of lipidoid-siRNA formulations for systemic delivery to the liver.
A. Akinc (2009)
a 14-day randomized study
Karsdal (2010)
a phase I doseescalation study
Simpkins (2013)
10.4049/jimmunol.0804182
Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
Y. A. Yeung (2009)
10.1124/jpet.109.158147
Transport across the Blood-Brain Barrier of Pluronic Leptin
T. Price (2010)
10.1016/S0264-410X(01)00225-0
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.
L. Jackson (2001)
10.1016/j.endonu.2013.09.003
An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
Panagiota Papargyri (2014)
10.1159/000351949
Current Understanding of Skin Biology Pertinent to Skin Penetration: Skin Biochemistry
P. W. Wertz (2013)
10.1021/bm701274p
Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.
K. Wood (2008)
10.1126/scitranslmed.3002230
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. J. Yu (2011)
10.1007/s11892-012-0313-4
Quality of Life and Technology: Impact on Children and Families With Diabetes
M. Hirose (2012)
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B . N .
J. S. Powell (2013)
10.1007/s11095-005-8110-2
Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis
Nada Abla (2005)
10.1002/mabi.201100325
Advances in polymeric systems for tissue engineering and biomedical applications.
R. Ravichandran (2012)
10.1158/2326-6066.CIR-13-0098
Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study
Fiona Simpkins (2013)
10.1126/scitranslmed.3002254
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
J. Atwal (2011)
10.1002/adhm.201200268
Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.
Jardin A Leleux (2013)
10.1038/nm.2198
Therapeutic cell engineering using surface-conjugated synthetic nanoparticles
M. Stephan (2010)
10.1002/jps.22190
Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
Sandeep Yadav (2010)
P 573 : Development of anti - SEMA 4 D monoclonal antibody for the treatment of multiple sclerosis
A. Jonason (2014)
10.5040/9781474247115.0051
The pilot study.
C. Baird (2000)
10.1016/j.jconrel.2012.12.008
Surfactant free preparation of biodegradable dendritic polyglycerol nanogels by inverse nanoprecipitation for encapsulation and release of pharmaceutical biomacromolecules.
D. Steinhilber (2013)
10.1002/jps.23229
A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life
J. Cleland (2012)
10.1007/978-1-4614-0554-2
Long Acting Injections and Implants
J. Wright (2012)
A novel glucagonlike peptide1 analog delivered orally reduces postprandial glucose excursion in a porcine model
M. Kidron (2013)
The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.
J. Cleland (1993)
10.1093/schbul/sbv138
Lessons Learned.
B. Fischer (2016)
10.1159/000351947
Engineering Approaches to Transdermal Drug Delivery: A Tribute to Contributions of Prof. Robert Langer
Samir Mitragotri (2013)
10.1016/S0049-3848(13)70150-6
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII.
S. Schulte (2013)
10.1073/PNAS.92.24.11234
Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.
S. Schwendeman (1995)
structure and degradation pathways
Kerwin (2008)
10.1002/adma.201003963
Hyaluronic acid hydrogels for biomedical applications.
J. Burdick (2011)
10.1038/sj.gt.3302439
Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4)
Y. Huang (2005)
skin biochemistry
Wertz (2013)
Strategies to Modulate Their Plasma HalfLives (ed
T. Hey (2012)
Wheat germ agglutinin functionalized complexation hydrogels for oral insulin
K. M. Wood (2008)
10.1023/A:1018943107688
Sustained Release of Human Growth Hormone from PLGA Solution Depots
K. J. Brodbeck (2004)
10.1074/jbc.M111.229633
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
Xiyun Chai (2011)
10.1021/nn500299p
Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.
Edward A. Sykes (2014)
10.1016/0142-9612(90)90018-L
Macromolecules released from polymers: diffusion into unstirred fluids.
M. Radomsky (1990)
10.1080/00498250701704819
Intestinal permeability and its relevance for absorption and elimination
H. Lennernäs (2007)
10.1158/0008-5472.SABCS13-P6-11-05
Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells
Je Lachowicz (2013)
SABER
Okumu (2002)
10.1073/pnas.1016152108
Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer
Tracy Hsu (2011)
P573: Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
A Jonason (2013)
10.1039/b913221j
Perfused multiwell plate for 3D liver tissue engineering.
K. Domansky (2010)
10.1371/journal.pone.0030341
CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder
P. Calias (2012)
10.1039/c3lc50234a
A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture.
I. Wagner (2013)
an immunological and materials perspective
J. Leleux (2013)
10.1208/s12249-010-9458-0
Ultrasound-Enhanced Drug Transport and Distribution in the Brain
Y. Liu (2010)
10.1056/NEJMe1313943
Antiamyloid therapy for Alzheimer's disease--are we on the right road?
E. Karran (2014)
10.1016/S0022-2836(02)01443-2
Effect of dextran on protein stability and conformation attributed to macromolecular crowding.
K. Sasahara (2003)
10.1021/mp9002267
Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.
C. Duvall (2010)
10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9
Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism.
H. Kim (1999)
10.1038/81359
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
J. Rothbard (2000)
10.1016/J.ADDR.2006.03.011
Formulation and delivery issues for monoclonal antibody therapeutics.
A. Daugherty (2006)
10.1126/scitranslmed.3005338
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch (2013)
10.1038/nrd1576
Cyclodextrin-based pharmaceutics: past, present and future
M. Davis (2004)
10.1128/CVI.00100-10
Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice
J. Song (2010)
10.1038/71916
Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)
Gaozhong Zhu (2000)
synthesis, characterization and evaluation in vitro and in vivo
Tong (2013)
10.1172/JCI46231
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.
J. LaBelle (2012)
10.1210/jc.2013-1437
A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults
K. Yuen (2013)
10.1073/pnas.1321744111
Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage
Jonathan M Brunger (2014)
10.1016/j.ejpb.2013.12.017
The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition.
Søren H Welling (2014)
10.1158/1535-7163.MCT-11-0820
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
C. McDonagh (2012)
reduction of Tau pathology and delay of disease progression
Chai (2011)
diffusion into unstirred fluids
M. L. Radomsky (1990)
10.1021/JA055287K
Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.
A. G. Ding (2006)
10.1111/j.1538-7836.2007.02386.x
Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis
E. A. Silva (2007)
10.1177/0091270007307242
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
S. Mousa (2007)
10.1016/S0378-5173(01)00920-6
Review on the systemic delivery of insulin via the ocular route.
Yung-Chi Lee (2002)
10.3109/9781420078077
Proteins and Peptides : Pharmacokinetic, Pharmacodynamic, and Metabolic Outcomes
R. Mrsny (2009)
10.1016/j.jconrel.2012.01.045
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
M. Rahman (2012)
10.1016/j.jconrel.2011.10.037
State of the art in PEGylation: the great versatility achieved after forty years of research.
G. Pasut (2012)
10.1007/978-1-62703-541-5
Antibody-Drug Conjugates
L. Ducry (2013)
10.1016/S0142-9612(02)00174-6
Sustained delivery of human growth hormone from a novel gel system: SABER.
F. Okumu (2002)
10.1002/JPS.20347
Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
J. Liu (2005)
10.1016/j.jconrel.2013.05.031
Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Sukyung Ahn (2013)
10.1023/A:1015841715384
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
S. Cohen (2004)
applications for insulin delivery
K. Whitehead (2004)
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia
Powell (2013)
10.1016/S0378-5173(03)00337-5
Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
Babu M. Medi (2003)
10.1371/journal.pone.0019338
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
E. Masliah (2011)
10.1016/0020-711x(89)90249-8
Transdermal Drug Delivery
P. Uzor (2012)
10.1016/j.jconrel.2012.04.020
In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.
S. Dünnhaupt (2012)
10.1007/s00774-004-0591-2
Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty
P. Peichl (2004)
10.1016/j.jconrel.2013.07.021
A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.
M. Amiram (2013)
10.1016/j.jconrel.2013.10.007
Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.
M. Chen (2014)
10.1007/s00431-012-1696-6
The effect of SonoPrep® on EMLA® cream application for pain relief prior to intravenous cannulation
D. Kim (2012)
10.1002/9783527644827
Therapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives
R. Kontermann (2012)
10.1002/bit.22983
Hydrophobic salts markedly diminish viscosity of concentrated protein solutions
Wei Du (2011)
Safety and immunogenicity of varying dosages of trivalent inactivated influenza
L. Jackson
10.1023/B:PHAM.0000019305.79599.a5
Poly(Lactide-Co-Glycolide) Microsphere Formulations of Darbepoetin Alfa: Spray Drying Is an Alternative to Encapsulation by Spray-Freeze Drying
P. A. Burke (2004)
10.1016/j.jconrel.2013.10.010
Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation.
Daniel T. Schweizer (2013)
10.1016/j.addr.2009.09.006
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
S. Maher (2009)
10.1002/JPS.21190
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
B. Kerwin (2008)
10.1089/dia.2009.0062
Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
J. Rosenstock (2009)
10.1002/(SICI)1520-6017(200006)89:6<732::AID-JPS4>3.0.CO;2-D
Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate.
H. Ravivarapu (2000)
Ninth Annual Diabetes Technology Meeting, 5–7 November 2009, San Francisco
M. Kidron (2010)
A novel glucagon - like peptide - 1 analog delivered orally reduces postprandial glucose excursion in a porcine model
S. Welling (2010)
10.1021/mp300126t
A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
Yi Wei (2012)
10.1016/j.jconrel.2009.01.003
Dynamic control of needle-free jet injection.
J. Stachowiak (2009)
10.1007/s11095-009-0033-x
Improved Lysozyme Stability and Release Properties of Poly(lactide-co-glycolide) Implants Prepared by Hot-Melt Extrusion
Zahra Ghalanbor (2009)
10.1016/J.JCONREL.2004.01.019
Injectable controlled release formulations incorporating protein crystals.
Sergey Pechenov (2004)
randomized, open-label, Phase I, repeat-dose study in healthy volunteers
J. Roberts (2014)
10.3109/03639041003682012
Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin
R. Rastogi (2010)
10.1126/science.7638603
Ultrasound-mediated transdermal protein delivery
S. Mitragotri (1995)
10.1038/nbt.1807
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti (2011)
10.1038/78682
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F. Bard (2000)
10.1016/J.MOLCEL.2006.08.020
A stapled BID BH3 helix directly binds and activates BAX.
L. Walensky (2006)
10.1080/10611860400020191
Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin
T. Yang (2005)
10.1016/j.molimm.2013.07.014
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.
M. G. Saifer (2014)
10.1038/NBT0298-153
Improving protein therapeutics with sustained-release formulations
S. D. Putney (1998)
10.1038/nature08956
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
M. Davis (2010)
10.1038/nbt.1601
Enhanced antibody half-life improves in vivo activity
J. Zalevsky (2010)
10.1201/9781420086836.ch15
Past, present--and future?
D. Holdstock (2005)
10.2165/00003088-200241070-00003
Clinical Pharmacokinetics of Depot Leuprorelin
P. Periti (2002)
10.1016/j.nano.2008.12.003
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.
M. Muthu (2009)
10.1021/bc200551b
Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
M. R. Sherman (2012)
10.1016/j.jconrel.2010.01.029
Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system.
Catherine E Kang (2010)
10.1016/j.jconrel.2009.05.003
Transcutaneous immunization using common chemicals.
P. Karande (2009)
10.1073/PNAS.90.9.4176
Controlled release of polypeptides from polyanhydrides.
E. Ron (1993)
10.1089/dia.2012.0101
Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus.
H. Zisser (2012)
10.1016/S1262-3636(11)70972-7
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
P. Schaepelynck (2011)
10.1021/cb1001153
Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein
James J. Cronican (2010)
10.1021/bc100204m
Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.
Suzanne R. Foster (2010)
10.1016/j.carbpol.2012.11.090
Conjugation of hyaluronan to proteins.
A. Mero (2013)
10.1016/J.DRUDIS.2006.08.005
Is the oral route possible for peptide and protein drug delivery?
M. Morishita (2006)
10.1073/PNAS.0600997103
Role of target geometry in phagocytosis.
J. Champion (2006)
10.1126/scitranslmed.3003276
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
Robert Farra (2012)
10.1016/S0301-472X(03)00006-7
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.
J. Egrie (2003)
10.1016/j.vaccine.2013.11.069
Nanoparticle vaccines.
L. Zhao (2014)
A placebo controlled single ascending dose Phase 1 for safety, tolerability, pharmacokinetics and pharmacodynamics of VRS-859
J L Cleland
10.1038/nbt.1588
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
V. Schellenberger (2009)
10.1016/j.jbiosc.2013.10.016
Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection.
Naoto Inoue (2014)
10.1093/nar/gkt710
Receptor-mediated delivery of engineered nucleases for genome modification
Z. Chen (2013)
10.1002/9783527644827.CH7
Half‐Life Extension through HESylation®
T. Hey (2012)
10.1126/SCIENCE.276.5320.1868
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
10.1073/pnas.052678899
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells
Y. Teng (2002)
10.1021/mp100102p
Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery.
Jing Tong (2010)
10.1371/journal.pone.0059524
Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
R. Eldor (2013)
10.1111/j.1463-1326.2008.00992.x
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects
M. Bush (2009)
10.1016/J.JCONREL.2004.04.013
Oral delivery of macromolecules using intestinal patches: applications for insulin delivery.
K. Whitehead (2004)
10.1126/scitranslmed.3008362
RNAi Therapies: Drugging the Undruggable
S. Wu (2014)
10.1021/mp300496x
Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo.
Jing Tong (2013)
10.1038/nbt1193
Transdermal protein delivery by a coadministered peptide identified via phage display
Y. Chen (2006)
10.1038/nrd3989
Deal watch: Chiasma and Roche partner in oral peptide drug delivery
Charlotte Harrison (2013)
10.1016/j.bpj.2014.02.036
Observation of small cluster formation in concentrated monoclonal antibody solutions and its implications to solution viscosity.
Eric J Yearley (2014)
Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
Jonason (2013)
A placebo controlled single ascending dose Phase 1 for safety, tolerability, pharmacokinetics and pharmacodynamics of VRS-859 in patients with T2DM (Poster)
J. L. Cleland (2011)
10.1073/pnas.1117147109
Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates
D. Santi (2012)
10.1016/j.brainres.2010.01.041
The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats
R. W. Sirianni (2010)
Novel approaches to ocular drug delivery.
J. Davis (2004)
10.1016/j.ejpb.2014.03.008
Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying.
Nathalie Bock (2014)
10.1056/NEJMoa1304369
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
D. V. Von Hoff (2013)
10.1038/NATURE08660
Direct inhibition of the NOTCH transcription factor complex
R. Moellering (2010)
10.1128/CVI.00435-10
Microneedle Vaccination with Stabilized Recombinant Influenza Virus Hemagglutinin Induces Improved Protective Immunity
W. Weldon (2011)
10.1126/scitranslmed.3007049
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Eric M. Pridgen (2013)
All About Albumin
J. Peters (1995)
Wearable and implantable pancreas
L. Ricotti (2013)
ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells
Lachowicz (2013)
10.1016/J.JCONREL.2005.10.029
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
M. Morishita (2006)
10.1016/J.ENDONU.2013.09.003
Estudio observacional de infusión subcutánea continua de insulina a lo largo de 7 años en el tratamiento de la diabetes mellitus tipo 1
Panagiota Papargyri (2014)
10.1016/j.chembiol.2011.07.003
A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.
James J. Cronican (2011)
10.1016/J.ADDR.2007.08.012
Spatiotemporal control over growth factor signaling for therapeutic neovascularization.
L. Cao (2007)
10.1016/j.medengphy.2011.12.010
Needle-free jet injection using real-time controlled linear Lorentz-force actuators.
A. Taberner (2012)
10.1016/j.biomaterials.2011.04.032
Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain.
M. Cooke (2011)
10.1021/bc8005122
Site-specific polysialylation of an antitumor single-chain Fv fragment.
A. Constantinou (2009)
10.1016/j.jconrel.2008.03.005
Discovery of synergistic permeation enhancers for oral drug delivery.
K. Whitehead (2008)
10.1073/pnas.1303002110
Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Yong Chang (2013)
Preclinical study of the cyclodextrinpolymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
S Gaur (2012)
Novel approaches to ocular drug
J. L. Davis (2004)
10.1093/HEAPRO/DAH110
Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses.
M. Kermode (2004)
10.1016/S0092-8674(00)80273-1
Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent
R. Ranganathan (1997)
10.1016/S0168-3659(01)00276-0
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs.
G. Zentner (2001)
10.4049/jimmunol.0903296
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki (2010)
10.1002/jps.23634
Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery.
K. Rajagopal (2013)
10.1517/17425247.2012.676040
Recent developments in buccal and sublingual delivery systems
S. Şenel (2012)
10.1089/dia.2011.0050
Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.
M. DeYoung (2011)
10.1080/10611860500471906
RETRACTED: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels
Nusrat A. Motlekar (2005)
10.1002/9780470593042.CH1
Drugging the "undruggable".
G. Verdine (2006)
In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas
Shuji Sasaki (2009)
10.1038/nmat3355
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.
Jineun Park (2012)
10.1016/j.bbagen.2013.04.023
Albumin as a versatile platform for drug half-life extension.
D. Sleep (2013)
from in vitro to the clinic
S. Maher (2009)
targeted gene knockout by direct delivery of zinc-finger nuclease proteins
T. Gaj (2012)
10.1016/j.jconrel.2013.09.004
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
V. Gupta (2013)
10.1007/s10047-012-0660-6
Wearable and implantable pancreas substitutes
L. Ricotti (2012)
10.1111/j.1463-1326.2009.01127.x
Review of clinical trials: update on oral insulin spray formulation
P. Pozzilli (2010)
10.1080/09205063.2013.803455
Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds
P. Mountziaris (2013)
10.1530/ENDOABS.35.P914
Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers
John Roberts (2014)
10.1016/j.joca.2009.08.004
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
M. Karsdal (2010)
10.1586/17434440.3.5.565
Needle-free liquid jet injections: mechanisms and applications
Joy Baxter (2006)
10.1073/pnas.1118425109
Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
D. Zheng (2012)
10.2147/IJN.S3061
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
10.1002/jps.23018
Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release.
W. Jiskoot (2012)
preparation and neuropharmacological evaluation
M. S. Muthu (2009)
10.1038/ncomms1607
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
J. Andersen (2012)
Effective targeting of the tumor microenvironment for cancer therapy.
P. Jiang (2012)
10.1038/263797A0
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
10.1016/J.REACTFUNCTPOLYM.2010.09.008
Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier.
Brian Albarran (2011)
10.1038/NMAT998
Multi-pulse drug delivery from a resorbable polymeric microchip device
A. Grayson (2003)
10.1016/S0142-9612(01)00089-8
Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein.
S. Eiamtrakarn (2002)
10.1056/NEJMoa1305074
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
J. Powell (2013)
10.2147/IJN.S2761
Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection
Eun-joo Park (2008)
10.1016/j.addr.2013.11.009
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
N. Bertrand (2014)
10.1182/BLOOD-2012-05-429688
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients.
E. Santagostino (2012)
10.1097/SLA.0b013e31825a02ab
Production and Implantation of Renal Extracellular Matrix Scaffolds From Porcine Kidneys as a Platform for Renal Bioengineering Investigations
G. Orlando (2012)
10.1002/JPS.21084
Oral delivery of antisense oligonucleotides in man.
L. Tillman (2008)
10.1126/science.1183057
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
K. Sugahara (2010)
Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation
R. Ranganathan (1997)
Pharmacokinetic, Pharmacodynamic, and Metabolic Outcomes 1st edn (eds Mrsny, R
Urtti (2010)
10.1111/J.1530-0277.2006.00052.X
Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
J. Dunbar (2006)
10.2337/dc11-0182
Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
E. Engwerda (2011)
10.1002/jbmr.1602
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
N. Binkley (2012)
10.1586/14737140.2013.840090
The role of Gliadel wafers in the treatment of high-grade gliomas
A. Bregy (2013)
10.1006/ABBI.1999.1175
Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding.
S. D. Allison (1999)
10.1021/bm301352x
Protein-polyanion interactions for the controlled release of monoclonal antibodies.
D. Schweizer (2013)
10.1177/000456329002700503
Laboratory Investigation of Cerebrospinal Fluid Proteins
E. Thompson (1990)
10.1016/J.NEURON.2013.12.007
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
K. Yanamandra (2013)



This paper is referenced by
10.2174/0929867324666170920163156
Cysteine-rich Proteins for Drug Delivery and Diagnosis.
G. Yang (2019)
10.3390/cancers11121855
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
L. Salvioni (2019)
10.3390/vaccines7040172
Recombinant Lactobacillus casei Expressing Capsid Protein VP60 can Serve as Vaccine Against Rabbit Hemorrhagic Disease Virus in Rabbits
L. Wang (2019)
10.1016/j.addr.2015.08.001
Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems.
Vu L Truong-Le (2015)
10.4155/tde-2016-0024
Delivering therapeutics in peripheral artery disease: challenges and future perspectives.
Mark H. M. Vries (2016)
10.1002/btm2.10036
Stimuli‐responsive delivery of therapeutics for diabetes treatment
J. Yu (2016)
10.1002/adhm.201700818
Cell‐Based Drug Delivery and Use of Nano‐and Microcarriers for Cell Functionalization
A. Timin (2018)
10.1002/ANGE.201712512
Translation durch Konvergenz: Drug‐Delivery‐Forschung in multidisziplinären Teams
G. Traverso (2018)
10.1016/j.biotechadv.2015.01.010
Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
M. Witting (2015)
Defining the mechanism behind the self-association of therapeutic monoclonal antibodies using mass spectrometric techniques
Paul W. A. Devine (2016)
10.1007/s10311-019-00871-3
Antimicrobial therapeutics delivery systems based on biodegradable polylactide/polylactide-co-glycolide particles
R. Kumar (2019)
Subcutaneous and oral delivery of insulin
Zakieh Al Kurdi (2015)
10.1016/j.ymeth.2019.11.013
Nano-Ghosts: Biomimetic Membranal Vesicles, Technology and Characterization.
Jacopo Oieni (2019)
10.1016/j.ejpb.2020.04.026
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
Nehal E Elsadek (2020)
10.1016/j.jconrel.2018.08.001
Subcutaneous delivery of monoclonal antibodies: How do we get there?
M. Viola (2018)
10.1080/25740881.2020.1750652
Dual stimuli-responsive polymeric hollow nanocapsules as “smart” drug delivery system against cancer
Rana Jahanban-Esfahlan (2020)
10.1016/J.CEJ.2018.09.096
Tunable zero-order drug delivery systems created by modified triaxial electrospinning
X. Liu (2019)
10.1021/mp500676e
Interactions of hyaluronic Acid with the skin and implications for the dermal delivery of biomacromolecules.
M. Witting (2015)
10.1007/s13233-020-8068-2
Outstanding Degradation Resistance of Hyaluronic Acid Achieved by Flavonoid Conjugations: Rheological Behavior
Kantappa Halake (2019)
10.1039/c9nr07334e
A modular approach for cytosolic protein delivery: metal ion-induced self-assembly of gold nanoclusters as a general platform.
Lirui Wang (2019)
10.1016/j.jconrel.2015.07.019
Cell membrane-camouflaged nanoparticles for drug delivery.
Brian T. Luk (2015)
10.1038/s41467-017-00952-3
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Y. Anraku (2017)
10.1201/9781315368863-12
Medical Application of Polyampholytes
Kazuaki Matsumura (2017)
10.1016/j.ijpharm.2016.06.054
Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
Yuko Iwase (2016)
10.1039/C6CS00409A
Lipid-based nanovesicles for nanomedicine.
N. Grimaldi (2016)
10.1021/acs.analchem.7b02447
Sensitive and Quantitative Detection of Anti-Poly(ethylene glycol) (PEG) Antibodies by Methoxy-PEG-Coated Surface Plasmon Resonance Sensors.
P. Zhang (2017)
10.1016/J.MOLLIQ.2019.03.064
Second osmotic virial coefficients of therapeutic proteins in the presence of excipient-mixtures can be predicted to aid an efficient formulation design
Miko Schleinitz (2019)
10.1021/acscentsci.5b00233
Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery
Hanxiang Zeng (2015)
10.1016/j.actbio.2016.11.012
Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
Carina Peres (2017)
10.3929/ETHZ-A-010792885
Engineered cytokine derivatives for targeted cancer immunotherapy
Dario Venetz (2016)
10.1038/s41598-017-00912-3
A novel 4-arm DNA/RNA Nanoconstruct triggering Rapid Apoptosis of Triple Negative Breast Cancer Cells within 24 hours
Joline Tung (2017)
10.7150/thno.26161
Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
H. Wang (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar